Abstract:ETHNOPHARMACOLOGICAL RELEVANCE:The morphological characteristics of Ganoderma cochlear (Blume & T. Nees) Bres were identical to G. sinsense J.D. Zhao, L.W. Hsu & X.Q. Zhang, however, with the fungus stipe lying in the back of the pileus. Fruiting bodies and spores of G. cochear have been traditionally used for smoothing, sleeping improvement, memory impairment, anti-aging, and prolonging life. Alzheimer's disease (AD) is a chromic progressive neurodegenerative disorder associated with loss of memory and cognition. Hallmarks of AD include aging, amyloid-β plaques, neurofibrillary tangles, neuron loss, neuronal degeneration, network disruption, cognitive dysfunction, inflammation and oxidation stress. In this study, norlanostanoids from G. cochear are identified as potential neurotrophic chemists related to the memory impairment usage to slow down pathogenetic process and restore neural circuits for AD.AIM OF STUDY:Chemical and biological investigations in this study uncovered the potential constituents related to the traditional usage of G. cochlear.MATERIALS AND METHODS:The extract of the mushrooms was purified using various column chromatography techniques and high-performance liquid chromatography (HPLC). The structures of the isolates were elucidated by combination of spectral, and single crystal X-ray diffraction analysis. The neurotrophic activity was evaluated by the differentiation state of PC12 cells, and the dose-dependent and time-dependant expression of growth-associated protein (GAP-43) was analyzed by western blotting.RESULTS:Ganorbifates J-T (1-11), eleven previously undescribed triterpenoids together with five known trinorlanostanoids (12-16) were isolated from the fruiting bodies of G. Cochlear. Among them, ganorbifates N-O (5-6) had a demethylation at C-28 compared to the classic skeleton of 3,4-seco-25,26,27-trinorlanostanoids to form a new group of 3,4-seco-25,26,27,28-tetranorlanostanoids. Based on this, a novel skeleton of ganorbifate M (4) was further established by the arrangement of C-29 from C-4 to C-7. A plausible biosynthetic pathway of compounds 4-6 was proposed. Eight of the sixteen isolates showed neurotrophic activity with the concentration of 10 μM. Furthermore, compound 15 exhibited a dose-dependent neurogenic activity, and also strengthened the expression of the growth-associated protein (GAP-43) in NGF-induced PC-12 cells, whereas 11 showed an inhibitory effect at higher concentration.CONCLUSION:These results demonstrated that 3,4-seco-norlanostanoids had reliable potential in promoting the outgrowth of PC-12 cells and could be used in the prevention and treatment of Alzheimer's disease, which is consist with the beneficial effects of G. Cochlear.

Triterpenoids and Meroterpenoids from the Edible Ganoderma Resinaceum and Their Potential Anti-Inflammatory, Antioxidant and Anti-Apoptosis Activities

Pharmacological Effects of Natural Ganoderma and Its Extracts on Neurological Diseases: A Comprehensive Review

Triterpenes and Aromatic Meroterpenoids with Antioxidant Activity and Neuroprotective Effects from Ganoderma lucidum

Ganoderterpene A, a New Triterpenoid from Ganoderma Lucidum, Attenuates LPS-Induced Inflammation and Apoptosis Via Suppressing MAPK and TLR-4/NF-κB Pathways in BV-2 Cells.

Neuroprotective Effects of a New Triterpenoid from Edible Mushroom on Oxidative Stress and Apoptosis Through the BDNF/TrkB/ERK/CREB and Nrf2 Signaling Pathway in Vitro and in Vivo.

Anti-inflammatory Effects of Ganoderma Lucidum Sterols Via Attenuation of the P38 MAPK and NF-κB Pathways in LPS-induced RAW 264.7 Macrophages

Protective Effect of Triterpenes of Ganoderma Lucidum on Lipopolysaccharide-Induced Inflammatory Responses and Acute Liver Injury.

Triterpenoids from functional mushroom Ganoderma resinaceum and the novel role of Resinacein S in enhancing the activity of brown/beige adipocytes

Lanostane triterpenoids with anti-proliferative and anti-inflammatory activities from medicinal mushroom Ganoderma lingzhi

Triterpenoids with neurotrophic activity from Ganoderma lucidum.

Anti-human immunodeficiency virus-1 protease activity of new lanostane-type triterpenoids from Ganoderma sinense.

Highly Oxygenated Chemical Constitutes and Rearranged Derivatives with Neurotrophic Activity from Ganoderma Cochlear

Triterpenes from antler-shaped fruiting body of Ganoderma lucidum and their hepatoprotective activities

The Biological Activity of Ganoderma lucidum on Neurodegenerative Diseases: The Interplay between Different Active Compounds and the Pathological Hallmarks

Ganospirones A-G, seven undescribed spiro-meroterpenoids from Ganoderma lucidum and their biological activities

Spiroganodermaines A−G from Ganoderma species and their activities against insulin resistance and renal fibrosis

Antioxidative and Cytoprotective Effects of Ganoderma Applanatum and Fomitopsis Pinicola in PC12 Adrenal Phaeochromocytoma Cells

Phenolic and Steroidal Metabolites from the Cultivated Edible Inonotus Hispidus Mushroom and Their Bioactivities

Anti-Adipogenic Lanostane-Type Triterpenoids from the Edible and Medicinal Mushroom Ganoderma applanatum

Antioxidant properties and antioxidant components of extracts from mushroom Ganoderma sinensis

Polyhydroxy Sterols Isolated From Ganoderma sinense Spores and Their Cytotoxic Activities